Mobile mammography company Texas Mobile Health of Houston is acquiringsystems connectivity developer Adaptive Video of Novato, CA. TexasMobile Health says it plans to use Adaptive Video's connectivityprowess to help link its facilities as the company
Mobile mammography company Texas Mobile Health of Houston is acquiringsystems connectivity developer Adaptive Video of Novato, CA. TexasMobile Health says it plans to use Adaptive Video's connectivityprowess to help link its facilities as the company expands.
Adaptive Video's Remote Access Image Management InformationSystem (RAIMIS) includes AD/V 1.5, a video framegrabber, and AD/VSpooler, a printer spooler. The company is moving from point-to-pointconnectivity solutions into networked connectivity with ImagePlex,a PC-based system for connecting legacy imaging devices with anetwork. ImagePlex recently received 510(k) clearance and willbe offered direct and through OEMs.
Texas Mobile Health runs four mobile mammography routes inTexas and Mississippi, and has aggressive plans for expandinginto other types of preventive services and other geographic regions,according to founder and president Chelette Baker.
Under the terms of the acquisition, the Texas Mobile Healthand Adaptive Video names will be retired and the companies willbe folded into a new firm, Basic Solutions International. TheAdaptive Video operations will focus on the technical developmentof imaging devices while the Texas Mobile Health business willprovide healthcare services. Basic Solutions will maintain headquartersin Novato and Houston.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.